The U.S. Food and Drug Administration (FDA) announced Rare Disease Evidence Principles (RDEP) to allow for faster approval of treatments for ultra-rare genetic diseases. A product is eligible if it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback